In an ever more crowded clinical trial landscape with trial activity on the increase but performance dropping, finding the right patients to recruit as participants is becoming a major challenge, and one which many sites do not master, ultimately putting the success at risk.
This white paper sets out to investigate the current trial landscape as well as the barriers to patient enrolment, laying out a technology-enabled approach to study feasibility and patient identification which promises to provide a fast and effective way of identifying the pool of eligible patients for primary care, specialty, and rare disease trials.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
